Figure 1From: Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey Patient perspectives on the discontinuation of imatinib treatment. A bar chart of patient perspectives on the discontinuation of imatinib treatment is shown. The proportion of patients indicating each reason is shown on the X axis.Back to article page